Taurone, S
Mounjaro (active ingredient: tirzepatide) subcutaneous injection Initial FDA Approval: 2022 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
15ml (1/2oz) Citations: 0
European Medicines Agency, Saxenda recommended for approval in weight management in adults
In this case, the levels of TMA in the blood and urine were measured before and after treatment, in addition to an next-generation sequencing (NGS) analysis of the intestinal microbiota
Payment Terms Cash Against Delivery (CAD), Letter of Credit (L/C), Western Union, Paypal, Cash in Advance (CID), Cash Advance (CA) Telegraphic Transfer (T/T) Supply Ability 10000 Per Week 1000 Per Week Main Export Market(s) Western Europe, Australia, South America, Eastern Europe, Middle East, Central America, Asia, North America, Africa Australia, Central America, North America, South America, Eastern Europe, Middle East, Asia, Western Europe, Africa People Also Viewed